# Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT

> **NCT05075837** · PHASE1 · UNKNOWN · sponsor: **Istituto Giannina Gaslini** · enrollment: 10 (estimated)

## Conditions studied

- Viral Infection After HSCT

## Interventions

- **BIOLOGICAL:** Virus -specific T cells

## Key facts

- **NCT ID:** NCT05075837
- **Lead sponsor:** Istituto Giannina Gaslini
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-27
- **Primary completion:** 2024-07-25
- **Final completion:** 2025-07-25
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05075837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05075837, "Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05075837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*